Your browser doesn't support javascript.
loading
Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure.
Kostyunin, Alexander E; Glushkova, Tatiana V; Lobov, Arseniy A; Ovcharenko, Evgeny A; Zainullina, Bozhana R; Bogdanov, Leo A; Shishkova, Daria K; Markova, Victoria E; Asanov, Maksim A; Mukhamadiyarov, Rinat A; Velikanova, Elena A; Akentyeva, Tatiana N; Rezvova, Maria A; Stasev, Alexander N; Evtushenko, Alexey V; Barbarash, Leonid S; Kutikhin, Anton G.
Afiliação
  • Kostyunin AE; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Glushkova TV; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Lobov AA; Department of Regenerative Biomedicine Research Institute of Cytology St. Petersburg Russian Federation.
  • Ovcharenko EA; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Zainullina BR; Centre for Molecular and Cell Technologies St. Petersburg State University Research Park St. Petersburg State University, Universitetskaya Embankment St. Petersburg Russian Federation.
  • Bogdanov LA; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Shishkova DK; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Markova VE; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Asanov MA; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Mukhamadiyarov RA; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Velikanova EA; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Akentyeva TN; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Rezvova MA; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Stasev AN; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Evtushenko AV; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Barbarash LS; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
  • Kutikhin AG; Department of Experimental Medicine Research Institute for Complex Issues of Cardiovascular Diseases Kemerovo Russian Federation.
J Am Heart Assoc ; 12(1): e028215, 2023 01 03.
Article em En | MEDLINE | ID: mdl-36565196
ABSTRACT
Background Whereas the risk factors for structural valve degeneration (SVD) of glutaraldehyde-treated bioprosthetic heart valves (BHVs) are well studied, those responsible for the failure of BHVs fixed with alternative next-generation chemicals remain largely unknown. This study aimed to investigate the reasons behind the development of SVD in ethylene glycol diglycidyl ether-treated BHVs. Methods and Results Ten ethylene glycol diglycidyl ether-treated BHVs excised because of SVD, and 5 calcified aortic valves (AVs) replaced with BHVs because of calcific AV disease were collected and their proteomic profile was deciphered. Then, BHVs and AVs were interrogated for immune cell infiltration, microbial contamination, distribution of matrix-degrading enzymes and their tissue inhibitors, lipid deposition, and calcification. In contrast with dysfunctional AVs, failing BHVs suffered from complement-driven neutrophil invasion, excessive proteolysis, unwanted coagulation, and lipid deposition. Neutrophil infiltration was triggered by an asymptomatic bacterial colonization of the prosthetic tissue. Neutrophil elastase, myeloblastin/proteinase 3, cathepsin G, and matrix metalloproteinases (MMPs; neutrophil-derived MMP-8 and plasma-derived MMP-9), were significantly overexpressed, while tissue inhibitors of metalloproteinases 1/2 were downregulated in the BHVs as compared with AVs, together indicative of unbalanced proteolysis in the failing BHVs. As opposed to other proteases, MMP-9 was mostly expressed in the disorganized prosthetic extracellular matrix, suggesting plasma-derived proteases as the primary culprit of SVD in ethylene glycol diglycidyl ether-treated BHVs. Hence, hemodynamic stress and progressive accumulation of proteases led to the extracellular matrix degeneration and dystrophic calcification, ultimately resulting in SVD. Conclusions Neutrophil- and plasma-derived proteases are responsible for the loss of BHV mechanical competence and need to be thwarted to prevent SVD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bioprótese / Próteses Valvulares Cardíacas / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Am Heart Assoc Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bioprótese / Próteses Valvulares Cardíacas / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Am Heart Assoc Ano de publicação: 2023 Tipo de documento: Article